Kevin Clive, MD
Surgery · Silverdale, WANPI 1780889808
Payments from drug & device makers
What this record shows
This record is dominated by education: $204,426 of the $288,739 with a category attached, or 70.8%. Intuitive Surgical accounts for 99.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $81,714 and has fallen 54.7% since, to $37,010 in 2025. Among surgery clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 324 payments — averaging $891.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$286K
- Medtronic$1K
- TELA Bio, Inc.$620
- Apollo Endosurgery US Inc$378
- Davol Inc.$270
- Johnson & Johnson$50
- plus $29 from 2 others
What the payments were for
- Speaking & faculty fees$58,60020%
- Travel & lodging$13,4585%
- Food & beverage$12,2544%
- Education$204,42671%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 297 | $286,052 |
| Medtronic | 12 | $1,340 |
| TELA Bio, Inc. | 3 | $620 |
| Apollo Endosurgery US Inc | 5 | $378 |
| Davol Inc. | 3 | $270 |
| Johnson & Johnson | 2 | $50 |
| Boston Scientific | 1 | $24 |
| Endogastric Solutions, Inc | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$288,739 in reported general payments places this provider in the 95th percentile of 549 surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aprepitant | 32 | $1,661 |
| Omeprazole | 77 | $886 |
| Scopolamine | 38 | $639 |
| Ondansetron OdtOndansetron | 21 | $143 |
| Ibuprofen | 22 | $94 |
| Tramadol Hcl | 46 | $89 |
Paid to pharmacies, not to this prescriber.
Other surgery in Silverdale
- Rajeev MisraSilverdale$183K
- Angel ReyesSilverdale$106K
- Marina ChengSilverdale$24K
- Matthew KleinSeattle$328K
- Adnan AlseidiSeattle$240K
- Prakash GattaTacoma$212K
- Aileen HwangIssaquah$195K
- Amir BastawrousSeattle$131K
- Alejandro ArnoldCovington$131K
- Brandon VanderwelShoreline$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.